A share price of Praxis Precision Medicines Inc [PRAX] is currently trading at $199.33, up 7.20%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PRAX shares have gain 4.90% over the last week, with a monthly amount glided 280.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Chardan Capital Markets started tracking the stock with Buy rating on May 07, 2025, and set its price target to $80. On March 03, 2025, H.C. Wainwright reiterated its Buy rating and revised its price target to $105 on the stock. Deutsche Bank started tracking the stock assigning a Buy rating and suggested a price target of $111 on February 11, 2025. Oppenheimer initiated its recommendation with a Outperform and recommended $134 as its price target on August 05, 2024. Needham started tracking with a Buy rating for this stock on June 24, 2024, and assigned it a price target of $145. In a note dated June 18, 2024, Guggenheim initiated an Buy rating and provided a target price of $155 on this stock.
Praxis Precision Medicines Inc experienced fluctuations in its stock price throughout the past year between $26.70 and $205.89. Currently, Wall Street analysts expect the stock to reach $245.33 within the next 12 months. Praxis Precision Medicines Inc [NASDAQ: PRAX] shares were valued at $199.33 at the most recent close of the market. An investor can expect a potential return of 23.08% based on the average PRAX price forecast.
Analyzing the PRAX fundamentals
Trailing Twelve Months sales for Praxis Precision Medicines Inc [NASDAQ:PRAX] were 7.76M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -34.98%, Pretax Profit Margin comes in at -32.33%, and Net Profit Margin reading is -32.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.6 and Total Capital is -0.67. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 187.55 points at the first support level, and at 175.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 205.55, and for the 2nd resistance point, it is at 211.78.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Praxis Precision Medicines Inc [NASDAQ:PRAX] is 6.31. As well, the Quick Ratio is 6.31, while the Cash Ratio is 3.24. Considering the valuation of this stock, the price to sales ratio is 621.40, the price to book ratio is 10.38.
Transactions by insiders
Recent insider trading involved Nemiroff Alex, General Counsel and Secretary, that happened on Nov 14 ’24 when 8239.0 shares were sold. Principal Accounting Officer, Mastrocola Lauren completed a deal on Nov 14 ’24 to sell 5188.0 shares. Meanwhile, Officer Mastrocola Lauren bought 5189.0 shares on Nov 14 ’24.
